During a recent Breakthrough T1D Facebook Live event, Mary Beth McNerney of Xeris Pharmaceuticals and Christine Beebe, MS, RD and Diabetes Educator discussed a new way to take charge of severe hypoglycemia episodes (“severe hypos”).
Joe Watterson, Breakthrough T1D Vice President of Corporate Development and McNerney delivered introductory remarks.
“We know that for people with diabetes on insulin, stress and erratic schedules increase the risk of severe low blood sugar,” McNerney said. “This increased risk plus the potentially limited access to hospitals because of COVID-19 puts the diabetes community in a very difficult position. But now because GVoke Hypopen is simple to use, it’s a solution you can count on if you or a loved one have a scary low where you feel like you might pass out.”
Dr. Beebe then addressed the following points:
- How often do people have very low blood sugar (hypoglycemia) episodes?
- What is glucagon and when should it be used?
- Details about Xeris’s GvokePFS (glucagon injection) Pre-Filled Syringe.
Watch the full, recorded livestream:
For more information about severe hypoglycemia, consult JDRF’s guidelines about hypoglycemia and JDRF’s hypoglycemia one-pager for parents and caregivers.
